Arcispedale Santa Maria Nuova — Reggio Emilia, Reggio Emilia

Public research footprint of Arcispedale Santa Maria Nuova, compiled from the ClinicalTrials.gov public registry.

260

Registered studies

Active

Recruiting now

126

Completed

Stopped or withdrawn

Most-studied conditions

HR Low-Positive/HER2-Negative Breast Neoplasms · Leukemia, Lymphocytic, Chronic, B-Cell · Follicular Lymphoma · Multiple Myeloma

Recently updated registry entries

NCT06191744 — Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral… (Active Not Recruiting)
NCT06966700 — A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast… (Recruiting)
NCT07007065 — Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Arcispedale Santa Maria Nuova?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.